Theratechnologies Inc.
THTX
$2.77
-$0.05-1.77%
NASDAQ
02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
---|---|---|---|---|---|
Net Income | 117.00K | -7.90M | 3.09M | 987.00K | -4.48M |
Total Depreciation and Amortization | 491.00K | 493.00K | 489.00K | 1.26M | 517.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.85M | 11.26M | 480.00K | 367.00K | 835.00K |
Change in Net Operating Assets | -12.20M | -4.08M | 544.00K | -2.91M | 1.42M |
Cash from Operations | -9.74M | -227.00K | 4.60M | -290.00K | -1.71M |
Capital Expenditure | -3.00K | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -6.90M | 166.00K | 779.00K | -137.00K | 134.00K |
Cash from Investing | -6.90M | 166.00K | 779.00K | -137.00K | 134.00K |
Total Debt Issued | 5.00M | 45.00M | -- | -- | -- |
Total Debt Repaid | -191.00K | -63.35M | -1.80M | -122.00K | -122.00K |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -144.00K | -359.00K | -65.00K | -517.00K | -153.00K |
Cash from Financing | 4.67M | -18.71M | -1.87M | -639.00K | -275.00K |
Foreign Exchange rate Adjustments | -13.00K | -25.00K | 9.00K | -8.00K | -8.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -11.99M | -18.79M | 3.52M | -1.07M | -1.86M |